Swine Health Improvement Plan: Biosecurity and Monitoring for Veterinarians

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• A swine health improvement plan integrates farm-specific biosecurity protocols with diagnostic surveillance to proactively manage disease risk, moving beyond reactive measures. This plan is a dynamic document requiring revision based on production changes, new pathogen introductions, or identified performance gaps.
• Risk assessment is foundational, identifying pathogen entry, spread, and persistence pathways considering geographic context, production type, and herd size; this informs the prioritization of biosecurity resources for highest-risk routes such as incoming animals, personnel, vehicles, and feed.
• External biosecurity focuses on preventing pathogen introduction through rigorous protocols for incoming animals (health status, quarantine), semen (boar stud surveillance), personnel (shower-in/out), vehicles (designated zones), and feed (sourcing, storage, treatment).
• Internal biosecurity aims to limit within-herd spread via optimized pig flow (all-in/all-out), strict sanitation between groups, controlled fomite movement (clean-to-dirty), and explicit protocols for mortality management and manure handling.
• Surveillance design utilizes oral fluids for efficient group-level pathogen detection (e.g., PRRSV, PCV2) and individual samples for confirmatory testing, with sampling frequency and diagnostic test selection (screening vs. confirmatory) dictated by pathogen epidemiology and surveillance objectives.
• Biosecurity audits, performed at least annually, systematically evaluate external and internal biosecurity domains using a risk-scoring system to identify high-risk findings and trigger corrective action plans with named responsibilities and timelines.

A swine health improvement plan is a written, farm-specific framework that aligns biosecurity practices with diagnostic surveillance so that disease risk is managed prospectively instead of reactively. This article provides the conceptual foundation and practical structure for veterinarians who design, implement, or audit such plans in commercial swine operations. It addresses the core question of how to translate disease risk assessment into measurable biosecurity protocols and monitoring schedules that produce actionable data.

The plan functions as a living document. It must be revised when production parameters change, when new pathogens enter a region, or when surveillance results reveal gaps between intended and actual biosecurity performance. The veterinarian's role is to define the risk profile, select monitoring targets, interpret results, and adjust protocols accordingly. This article covers the scientific basis for risk assessment, the design of external and internal biosecurity layers, and the selection of sampling strategies and diagnostic tests. Vaccination program design is outside the scope of this article.

Disease control in swine production depends on systematic processes because clinical observation alone is too slow and too inaccurate to support effective health management decisions. This principle applies equally to endemic pathogens such as porcine reproductive and respiratory syndrome virus (PRRSV) and to epizootic threats such as classical swine fever virus (CSFV), which remains notifiable to the World Organization for Animal Health due to its severe economic impact and the strict stamping-out policies required for regional eradication. A health improvement plan therefore serves two functions: it reduces the probability of pathogen introduction and spread, and it generates the surveillance data needed to detect incursions early and document freedom from disease.

At a Glance

Risk Assessment as the Foundation

A health improvement plan begins with a structured risk assessment that identifies how pathogens could enter the herd, spread within it, and persist. The assessment must consider the operation's geographic context, including regional disease prevalence and proximity to other swine facilities, as well as production type, herd size, and pig flow. Grow-finish sites, farrow-to-wean operations, and breeding herds each present distinct risk profiles, and the plan must reflect those differences instead of apply a generic template.

The risk assessment should be scored or ranked so that biosecurity resources are allocated to the highest-risk pathways. Common entry routes include replacement stock, semen, personnel, vehicles, feed ingredients, and fomites. Airborne transmission matters for some pathogens, particularly PRRSV, and should be evaluated when sites are in high-density swine areas. The output of the risk assessment is a prioritized list of pathways with corresponding mitigation measures, each assigned to a named individual with a defined timeline for implementation.

External Biosecurity: Preventing Pathogen Introduction

External biosecurity comprises the measures that prevent pathogen entry into the herd. The most critical decision is the health status of incoming animals and semen, because these are the highest-risk introductions. Replacement stock should come from herds with documented health status and should be quarantined and acclimated according to a written protocol. Semen should be sourced from boar studs with active surveillance programs.

Personnel and vehicle movement require explicit protocols. Shower-in, shower-out procedures, site-specific clothing and boots, and designated loading areas with clear separation between clean and dirty zones are standard components. Feed biosecurity has gained attention because feed ingredients can serve as vehicles for viral pathogens. Medium-chain fatty acids and monoglycerides have been investigated as feed additives with inhibitory activity against viral and bacterial pathogens, and they represent one option for feed pathogen mitigation, though their efficacy varies by pathogen and matrix. The plan should specify feed ingredient sourcing, storage, and treatment protocols based on current risk.

Internal Biosecurity: Limiting Within-Herd Spread

Internal biosecurity addresses pathogen spread once it has entered the herd. The central principle is pig flow design. All-in, all-out production by room or by site reduces pathogen carryover between groups, whereas continuous flow allows endemic pathogens to persist. The plan should document the flow pattern for each barn and define the sanitation procedures between groups, including cleaning, disinfection, drying, and downtime.

Fomite movement within the farm requires the same discipline as external movement. Equipment, tools, and supplies should be assigned to specific areas, and movement between areas should follow a clean-to-dirty direction. Needles, gloves, and other single-use items should never be shared between litters or groups. Mortality management and manure handling also present internal transmission risks and should be addressed explicitly in the plan.

Surveillance Design and Diagnostic Logic

Surveillance is the measurement arm of the health improvement plan. It must be designed to answer specific questions: Is the herd free of a target pathogen? Is a control program working? Is a new strain emerging? The sampling strategy, specimen type, and test selection all follow from the question being asked.

Oral fluids have become a standard surveillance specimen because they allow efficient group-level sampling across large populations. Research has demonstrated the detection of more than 20 swine viral pathogens in oral fluids, and protocols exist for collection, handling, and testing that support routine surveillance in herds exceeding 12,000 pigs. Oral fluids are well suited for PRRSV and porcine circovirus type 2 monitoring, but they are not optimal for every pathogen or every question. Individual pig sampling remains necessary for confirmatory testing, for pathogens with low oral fluid shedding, and for regulatory purposes.

Test selection must match the surveillance objective. Screening tests prioritize sensitivity to avoid missing positive samples, while confirmatory tests prioritize specificity to avoid false positives. The veterinarian must understand the performance characteriztics of each assay in the context of the target pathogen and the population being sampled. MSD Veterinary Manual diagnostic resources provide a practical reference for assay selection and interpretation. Sampling frequency should be risk-based, with higher frequency during high-risk periods such as gilt introduction, seasonal PRRSV outbreaks, or when regional disease pressure increases.

Biosecurity Audit Template and Scoring

A structured audit converts biosecurity principles into repeatable, measurable practice. The audit should be performed at least annually and after any disease event that suggests a breakdown. The veterinarian walks the entire site with the production manager, using a standardized checklist that separates external and internal biosecurity domains.

Each domain receives a risk score based on the probability of pathogen transfer and the consequences of that transfer. Score 0 for no risk, 1 for low risk, 2 for moderate risk, and 3 for high risk. A domain score above 12, or any single item scored 3, triggers a written corrective action plan with a named responsible person and a completion date.

The audit template must be adapted to production system. Farrow-to-wean sites carry different risks than finishing sites or multisite systems. For multisite operations, audit each site separately and assess the movement of pigs, personnel, and equipment between sites as its own domain. WOAH terrestrial animal health standards provide the international framework for compartmentalisation and regionalisation that can be referenced when defining the epidemiological unit for audit purposes.

Monitoring Schedule Design

The monitoring schedule converts herd health objectives into a calendar of diagnostic activities. Design the schedule around three questions: what pathogen or production parameter is being tracked, what sample type and test will detect it, and what action threshold triggers a response.

For breeding herds, monthly sampling of oral fluids from the gestation and farrowing areas provides a practical basis for PRRSV and influenza A virus surveillance. Guidelines for oral fluid-based surveillance of viral pathogens in swine describe collection methods and testing applications validated for large populations, including herds exceeding 12,000 pigs. Oral fluids detect group-level prevalence efficiently but do not identify individual animals, so follow-up individual sampling is required when a positive result appears.

The schedule below represents a baseline program for a breeding herd in a region with endemic PRRSV and influenza. Adjust intervals based on disease status, season, and production phase.

Interpreting Diagnostic Results and Adjusting the Plan

A single positive PCR result does not justify a change in the health plan. Interpret results in the context of Ct values, sample quality, and clinical history. A high Ct value in a stable herd may represent low-level circulation that requires monitoring instead of intervention. A low Ct value in a previously negative herd demands immediate action, including quarantine of the affected group and enhanced sampling of adjacent groups.

For PRRSV, genotype the isolate whenever a new introduction is suspected. Compare the sequence to the herd's resident strain and to regional strains. A match with the resident strain indicates ongoing circulation instead of a new introduction, which shifts the response from external biosecurity review to internal control measures.

Influenza A virus results require subtype characterization because vaccine strain matching affects protection. Sample selection matters: oral fluids detect group-level shedding, but nasal swabs from acutely affected pigs provide better material for virus isolation and antigenic characterization. MSD Veterinary Manual provides species-specific guidance on sample collection and interpretation for respiratory pathogens.

Documentation and Review Cycles

Documentation serves two purposes: it creates a record for regulatory and trade purposes, and it provides the data needed to evaluate whether the plan is working. Maintain a herd health file that contains the biosecurity audit, the monitoring schedule, all diagnostic results, and the corrective action log.

Review the complete health plan quarterly with the production team. The review should compare diagnostic results against action thresholds, assess whether corrective actions were completed, and adjust the schedule based on changes in disease status or production system. USDA APHIS animal health information and FAO animal production and health guidance describe national and international reporting expectations that may apply depending on the pathogen and jurisdiction.

Regional and Regulatory Considerations

The monitoring schedule must accommodate notifiable disease obligations. Classical swine fever is notifiable to the World Organization for Animal Health, and control policies in affected regions include stamping out with or without vaccination. A review of classical swine fever virus biology and control describes the diagnostic tools and surveillance challenges relevant to CSF eradication programs. Where CSF is present regionally, the monitoring schedule must include clinical inspection for hemorrhagic signs and immediate reporting of suspect cases, regardless of the routine sampling calendar.

Feed-based pathogen mitigation is an adjunct to, not a replacement for, biosecurity and monitoring. Medium-chain fatty acids and monoglycerides as feed additives for pig production summarize evidence that these compounds can reduce pathogen survival in feed, but the veterinarian should treat feed additives as one layer of a multi-layered control program. The evidence base for specific additives varies by pathogen and production stage, and current product labels and published efficacy data should be consulted before adoption.

The correct monitoring interval depends on the pathogen's transmission dynamics, the production system, and the consequences of missing an introduction. A high-health nucleus herd with valuable genetics justifies more intensive sampling than a commercial finishing site. The veterinarian should document the rationale for each interval so that changes can be made deliberately instead of reactively.

Recognized Failure Modes and Early Detection

Biosecurity and monitoring plans fail in predictable patterns. The most common failure is silent degradation of compliance, where protocols exist on paper but are not executed consistently. This is detected early through audit scores that decline between scheduled reviews, through discrepancies between written protocols and observed practices, and through employee interviews that reveal uncertainty about specific procedures. A second frequent failure is sample quality deterioration, particularly with oral fluids. Rope chewed to fraying, contaminated collection containers, or pools that sit for hours before refrigeration produce results that mislead instead of inform. The guidelines for oral fluid-based surveillance of viral pathogens in swine specify collection methods and handling requirements that directly affect diagnostic validity.

A third failure mode is diagnostic drift, where the testing laboratory, assay platform, or sample matrix changes without recalibration of interpretation thresholds. Cycle threshold values from PCR assays are not interchangeable across laboratories or reagent lots. A herd that appears to improve may simply be tested with a less sensitive assay. Early detection requires tracking assay characteriztics alongside results and confirming apparent trends with a parallel sample set when a laboratory or platform change occurs.

The fourth common failure is temporal blindness, where sampling intervals are too long to detect an incursion before secondary spread. This is detected by reviewing the interval between the last negative sample and the first positive detection, then comparing that interval against the known incubation period of the target pathogen. If the detection lag exceeds the incubation period, sampling frequency is insufficient.

Common Errors and Corrective Action

Less experienced clinicians often design monitoring around diagnostic convenience instead of epidemiological question. Testing the easiest accessible group, such as nursery pigs near the alley, biases detection toward the animals most likely to be sampled and away from the groups at highest risk of introduction. The corrective action is to map the sampling plan against the movement of animals, people, and fomites through the facility, then select sampling points that intersect the highest-risk pathways.

A second recurring error is over-interpretation of single positive results. A single oral fluid positive for a pathogen that circulates endemically does not indicate an outbreak, and a single negative does not confirm freedom. The corrective action is to establish baseline prevalence expectations for each pathogen and to require either consecutive positives or an increase in detection frequency before escalating the response. This is particularly relevant for pathogens with endemic circulation where classical swine fever virus control programs have demonstrated that surveillance interpretation depends on the epidemiological context of the region.

A third error is neglecting the diagnostic sensitivity of the sample matrix itself. Oral fluids detect group-level prevalence efficiently but have different sensitivity profiles than individual serum samples for different pathogens and stages of infection. Clinicians who switch matrices without validating the change against the surveillance objective will misread results. The corrective action is to document the matrix, the target pathogen, and the detection limit for each assay in the monitoring protocol.

Evidence Limitations and Divergent Expert Opinion

The evidence base for swine biosecurity and monitoring is uneven. Oral fluid surveillance has strong validation for porcine reproductive and respiratory syndrome virus and porcine circovirus type 2, but the guidelines for oral fluid-based surveillance note that detection of other pathogens is less thoroughly characterized. Sampling frequency recommendations, pooling strategies, and interpretation thresholds for less common pathogens rest on thinner evidence, and expert opinion diverges on whether oral fluids can replace individual animal sampling for certification purposes.

Feed-based pathogen mitigation is another area where evidence is developing. Medium-chain fatty acids and monoglycerides as feed additives show inhibitory activity against viral and bacterial pathogens in experimental systems, but field efficacy under commercial conditions is less certain. Some practitioners incorporate these additives as a routine biosecurity layer, while others reserve them for high-risk periods. Both positions are defensible given the current evidence.

Regional differences in disease pressure and regulatory frameworks mean that a monitoring plan validated in one production system cannot be assumed to transfer to another. The WOAH terrestrial animal health standards provide international reference points, but national programs may impose additional requirements or different surveillance expectations.

Escalation and Referral Criteria

Escalation is warranted when monitoring detects a pattern consistent with new introduction of a notifiable pathogen, when clinical signs suggest a disease with trade implications, or when diagnostic results are inconsistent with the clinical picture. Regulatory reporting obligations vary by jurisdiction, and the veterinarian should confirm the local requirements through the relevant animal health authority, such as the USDA APHIS animal health information for United States producers or the FAO animal production and health guidance for international contexts.

Laboratory involvement is indicated when results are ambiguous, when confirmatory testing is required by regulation, or when a novel or unexpected pathogen is suspected. Specialist consultation is appropriate when the herd has failed to respond to two consecutive plan adjustments, when the differential diagnosis includes pathogens requiring specialised diagnostic capacity, or when the economic consequences of continued uncertainty exceed the cost of external expertise.

Frequently Asked Questions

How Should I Prioritize Biosecurity Investments When the Operation Has Limited Capital?

Prioritize interventions that address the highest-risk transmission pathways identified in your risk assessment, not the most visible or most expensive options. A perimeter fence and a functional shower-in facility outperform an expensive diagnostic laboratory if the primary risk is wildlife contact or visitor entry. Target the top three scored risks from your audit template first. Oral fluid sampling requires minimal equipment and can be implemented before more costly individual animal testing programs, as described in guidelines for oral fluid-based surveillance in swine. Reallocate funds from low-yield activities, such as routine testing of low-risk groups, toward the identified gaps. Document the rationale for each priority decision so the producer understands the logic.

What Is the Minimum Viable Monitoring Program When Diagnostic Budgets Are Severely Restricted?

A minimum program samples the highest-risk production stage monthly using pooled oral fluids instead of individual samples. Target breeding herd entry and the grow-finish period, where most pathogen introductions and amplifications occur. Test for the two or three pathogens with the greatest regional impact, and use the results to trigger targeted testing instead of continuous surveillance. When laboratory access is limited, coordinate sampling with the herd veterinarian's scheduled visits to reduce shipping costs. The WOAH terrestrial animal health standards provide guidance on surveillance intensity appropriate to disease status and trade requirements. A reduced program still requires written protocols, defined action thresholds, and a review date. Communicate clearly that a minimum program detects major events but provides less sensitivity for slow or low-prevalence introductions.

How Do I Adapt These Protocols for a Small Herd or a Non-Commercial Operation?

Small herds require the same risk assessment logic but simpler implementation. Individual animal sampling replaces pooled oral fluids when group sizes are too small for meaningful pooling. The biosecurity perimeter may be a single gate instead of a multi-stage entry system, but the principle of clean and dirty zones remains unchanged. Record keeping can be a paper logbook if electronic systems are impractical, provided entries are consistent and reviewed. The FAO animal production and health guidance addresses biosecurity and monitoring adaptations across production scales and regions. For non-commercial operations, focus on preventing contact with neighboring swine and feral populations, since these are often the highest-risk pathways. Adjust action thresholds to account for the smaller population, where a single positive result carries greater significance than in a large herd.

What Records Must I Maintain to Demonstrate Biosecurity and Monitoring Compliance?

Maintain three record categories: entry logs, movement logs, and diagnostic results. Entry logs document all people, vehicles, and equipment entering the clean zone, including dates and biosecurity procedures completed. Movement logs track pig movements between groups, buildings, and sites, plus any off-farm movements. Diagnostic records should include sampling dates, sample types, tests performed, results, and the action taken in response to each result. The USDA APHIS animal health information resources describe record requirements relevant to national disease programs and traceability. Review records at each scheduled plan review and use them to identify recurring biosecurity breaches. Records must be legible, dated, and retained for a period specified in your practice protocol or regional requirements. Electronic spreadsheets are acceptable if they are backed up and accessible during an audit.

How Do I Explain a Biosecurity Finding to a Producer Who Disagrees With the Assessment?

Present the finding as a measured risk, not a criticism. Show the producer the specific pathway, the evidence for it, and the potential consequence using their own herd data where possible. Compare the cost of the recommended control against the estimated cost of a disease outbreak, using conservative figures. Reference the MSD Veterinary Manual professional resources for background on disease transmission risks when the producer requests additional reading. Acknowledge valid constraints such as labor availability or facility limitations, and offer a phased approach that addresses the highest-risk finding first. If disagreement persists, document the discussion and the producer's decision, then propose a short trial period for the recommended change with a defined review date. This converts a conflict into a testable intervention.

When Should I Refer a Herd to a Specialist or Regional Diagnostic Laboratory?

Refer when the monitoring program detects a pattern you cannot interpret with available data, when clinical signs suggest a notifiable disease, or when the herd is not responding to standard interventions. Immediate referral is required for any suspicion of a WOAH-notifiable disease such as classical swine fever, which mandates official notification and coordinated response under international animal health standards. Refer also when specialized testing such as whole-genome sequencing, histopathology, or exotic pathogen exclusion is needed and your routine laboratory cannot provide it. Establish referral relationships before an emergency arises. Provide the receiving laboratory or specialist with the complete monitoring history, also the recent results, since temporal patterns often clarify diagnostic interpretation. Document the referral and its outcome in the herd record.

Related Clinical & Scientific Guides

• Rumen Health Assessment in Dairy Cows: Clinical and Subclinical Indicators
• Mastitis Control Programs in Dairy Herds: Monitoring and Prevention
• Swine Nutrition and Health: Feed-Related Disease Diagnosis

References and Further Reading

• Classical swine fever virus: the past, present and future.. 2020.
• Medium-chain fatty acids and monoglycerides as feed additives for pig production: towards gut health improvement and feed pathogen mitigation.. 2020.
• Spirulina as a livestock supplement and animal feed.. 2013.
• Guidelines for oral fluid-based surveillance of viral pathogens in swine.. 2020.
• Impacts of Epigenetic Processes on the Health and Productivity of Livestock.. 2020.
• Significant improvement in cloning efficiency of an inbred miniature pig by histone deacetylase inhibitor treatment after somatic cell nuclear transfer.. 2009.
• USDA APHIS Animal Health Information. USDA APHIS.
• FAO Animal Production and Health. FAO.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Swine Herd Health Monitoring: Key Indicators and Diagnostic Tools
• Swine Herd Biosecurity: External and Internal Measures
• Biosecurity Planning for Swine Operations: Risk Assessment and Implementation
• Dairy Cow Hoof Health: Trimming Programs and Lesion Monitoring
• Herd Health Plan Design for Beef Cow-Calf Operations

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.